Literature DB >> 8813351

Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.

T Pirttilä1, H Soininen, O Heinonen, T Lehtimäki, N Bogdanovic, L Paljärvi, O Kosunen, B Winblad, P Riekkinen, H M Wisniewski, P D Mehta.   

Abstract

We measured apolipoprotein E (apoE) level in neutral and acidic pH extracts of the frontal, temporal and cerebellar cortices from patients with definite Alzheimer's disease (AD) and controls, and analyzed the relationship among apoE levels, clinical and neuropathological findings, and apoE genotype. Our data showed that the levels varied in different brain regions being lowest in the frontal cortex and highest in the cerebellum in Ad brains. ApoE levels in neutral pH extracts from the frontal cortex from AD patients were significantly lower than those of controls, and correlated negatively with the number of neurofibrillary tangles. ApoE genotype was not associated with the levels of apoE. There was no correlation between apoE levels and amyloid load or synaptophysin-immunoreactivity in the brain. We conclude that apoE levels are not increased in AD brains. However, apoE levels vary in different brain regions, and local factors related to the synthesis and metabolism of apoE may be crucial in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813351     DOI: 10.1016/0006-8993(96)00183-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

Authors:  C Russo; G Angelini; D Dapino; A Piccini; G Piombo; G Schettini; S Chen; J K Teller; D Zaccheo; P Gambetti; M Tabaton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

3.  Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice.

Authors:  Nga Bien-Ly; Anna K Gillespie; David Walker; Seo Yeon Yoon; Yadong Huang
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

Review 4.  ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.

Authors:  Yonghe Li; Jesse R Macyczko; Chia-Chen Liu; Guojun Bu
Journal:  Neurobiol Aging       Date:  2022-03-22       Impact factor: 5.133

Review 5.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

6.  APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.

Authors:  Annah M Moore; Emily Mahoney; Logan Dumitrescu; Philip L De Jager; Mary Ellen I Koran; Vladislav A Petyuk; Renã As Robinson; Douglas M Ruderfer; Nancy J Cox; Julie A Schneider; David A Bennett; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2019-11-05       Impact factor: 4.673

7.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.

Authors:  Sonia Sanz Muñoz; Hongyun Li; Kalani Ruberu; Qian Chu; Alan Saghatelian; Lezanne Ooi; Brett Garner
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

8.  Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

Authors:  P van Vliet; R G J Westendorp; P Eikelenboom; H C Comijs; M Frölich; E Bakker; W van der Flier; E van Exel
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

Review 9.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 10.  Transcriptional regulation and its misregulation in Alzheimer's disease.

Authors:  Xiao-Fen Chen; Yun-wu Zhang; Huaxi Xu; Guojun Bu
Journal:  Mol Brain       Date:  2013-10-21       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.